Case Study: From Risk To Resolution: A Groundbreaking Approach To Nitrosamine Mitigation - Adare Pharma Solutions

Adare Pharma Solutions on LinkedIn

When the FDA reached out to Adare Pharma Solutions regarding potential nitrosamine formation in a beta blocker, our experts quickly developed an effective in-depth process to mitigate impurities in all commercial products.

Please complete the form below in order to access our resource:

"*" indicates required fields

Personal details

First Name*

Last Name*

Email*

Phone

Company

Name*

Country*

Industry

State/Province*

Hidden

Province/Territory*

What is your Primary area of Interest? (legacy)

Focus Area(s)*

Stage of Program

Timing of Need

Hidden

Resource*

Hidden

Web Leads*

Hidden

LeadSource*

Hidden

Campaign Name*

Hidden

Download Type

Hidden

Download Title

Hidden

OwnerId*

Let us know how we can help

Please be specific

<p>By ticking this box, you acknowledge and agree to our GDPR compliance and privacy policy</p>*

By ticking this box, you acknowledge and agree to our GDPR compliance and privacy policy

<p>opt-in for SMS marketing</p>

By ticking this box, you agree to opt-in to SMS Marketing

CAPTCHA

©2024 Adare Pharma Solutions. All rights reserved

Machine Readable Files (cigna.com) Machine Readable Files (anthem.com)

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others